CVS Health hiked its 2025 forecast above Wall Street's expectations after improving Medicare benefits contributed to a better ...

Eli Lilly's stock wobbled Thursday after a looming coverage hit was detailed for its blockbuster weight-loss drug Zepbound.

CVS Health shares powered 9% higher before the bell Thursday after the pharmacy and healthcare giant's first-quarter results ...

U.S. stocks were higher, with the Dow Jones index gaining around 400 points on Thursday. Shares of CVS Health Corporation CVS ...

CVS Health topped Q1 estimates with $94.59 billion in revenue and raised 2025 EPS outlook to $6.00–$6.20 amid strong Medicare ...

Eli Lilly (LLY) stock dips as CVS Health (CVS) limits access to its weight loss drug Zepbound in favor of Novo Nordisk's (NVO ...

CVS Health recorded a net income of $1.8 billion in the first quarter of 2025, up from $1.1 billion during the same period last year.

CVS reported first quarter earnings Thursday, blowing past Wall Street's expectations and ending anxiety over Medicare ...

The Department of Justice filed a complaint against health insurers CVS Health-unit Aetna, Elevance Health and Humana, alleging they paid the kickbacks to insurance brokers eHealth, GoHealth and ...

Eli Lilly & Co.’s shares fell the most intraday since October after CVS Health Corp. announced a plan to drop its blockbuster ...

Pharmacy benefits costs continue to rise faster than medical insurance costs, and the "ongoing upward pressure and complexity ...